Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan

Abstract Renal injury is common in patients with coronavirus disease 2019 (COVID‐19). We aimed to determine the relationship of estimated glomerular filtration rate (eGFR) and acute kidney injury (AKI) with the characteristics, progression, and prognosis of COVID-19 in-patients. We retrospectively r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kehong Chen, Yu Lei, Yani He, Fei Xiao, Yan Yu, Xiaodong Lai, Yang Liu, Jiang Wang, Huanzi Dai
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8d31feb4fb1a40e08e774fcf98e19b0e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d31feb4fb1a40e08e774fcf98e19b0e
record_format dspace
spelling oai:doaj.org-article:8d31feb4fb1a40e08e774fcf98e19b0e2021-12-02T16:31:02ZClinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan10.1038/s41598-021-94570-12045-2322https://doaj.org/article/8d31feb4fb1a40e08e774fcf98e19b0e2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94570-1https://doaj.org/toc/2045-2322Abstract Renal injury is common in patients with coronavirus disease 2019 (COVID‐19). We aimed to determine the relationship of estimated glomerular filtration rate (eGFR) and acute kidney injury (AKI) with the characteristics, progression, and prognosis of COVID-19 in-patients. We retrospectively reviewed 1851 COVID-19 patients admitted to 3 hospitals in Wuhan, China. Clinical, laboratory, radiological, treatment, complication, and outcome data were analyzed. Patients were stratified according to levels of eGFR (≥ 90 vs. 60–89 vs. < 60 mL/min/1.73 m2). The risk of reaching the composite endpoint—intensive care unit admission, invasive ventilation, or death—was compared. On admission, 25.5% patients had renal impairment (eGFR < 90 mL/min/1.73 m2), but only 2.6% patients had chronic kidney disease (CKD). The overall in-hospital AKI incidence was 6.7%. Severe illness and comorbidities (hypertension, diabetes, CKD, and cardiovascular/cerebrovascular diseases) were more common among patients with low eGFR (< 90 mL/min/1.73 m2). Despite the more frequent use of intensive oxygen therapy, continuous blood purification, and glucocorticoid treatment, the prognosis of these patients was unsatisfactory, with the incidence of the composite endpoint (15.4% vs. 19.6% vs. 54.5%; P = 0.000) and complications (AKI, respiratory failure, cardiac injury, coagulation disorders, sepsis, etc.) increasing with decreasing eGFR. Kaplan–Meier survival analysis revealed that patients with eGFR < 90 mL/min/1.73 m2 or AKI had significantly escalated risks of reaching the composite endpoint. Multivariate regression analysis showed that renal insufficiency (eGFR < 60 mL/min/1.73 m2) on admission and in-hospital AKI independently predicted poor prognosis among COVID-19 in-patients. And renal impairment on admission was a greater predictor of poor prognosis in non-elderly patients than that in elderly patients. Early and continuous renal-function monitoring and early AKI diagnosis are necessary to predict and prevent the progression of COVID-19.Kehong ChenYu LeiYani HeFei XiaoYan YuXiaodong LaiYang LiuJiang WangHuanzi DaiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kehong Chen
Yu Lei
Yani He
Fei Xiao
Yan Yu
Xiaodong Lai
Yang Liu
Jiang Wang
Huanzi Dai
Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan
description Abstract Renal injury is common in patients with coronavirus disease 2019 (COVID‐19). We aimed to determine the relationship of estimated glomerular filtration rate (eGFR) and acute kidney injury (AKI) with the characteristics, progression, and prognosis of COVID-19 in-patients. We retrospectively reviewed 1851 COVID-19 patients admitted to 3 hospitals in Wuhan, China. Clinical, laboratory, radiological, treatment, complication, and outcome data were analyzed. Patients were stratified according to levels of eGFR (≥ 90 vs. 60–89 vs. < 60 mL/min/1.73 m2). The risk of reaching the composite endpoint—intensive care unit admission, invasive ventilation, or death—was compared. On admission, 25.5% patients had renal impairment (eGFR < 90 mL/min/1.73 m2), but only 2.6% patients had chronic kidney disease (CKD). The overall in-hospital AKI incidence was 6.7%. Severe illness and comorbidities (hypertension, diabetes, CKD, and cardiovascular/cerebrovascular diseases) were more common among patients with low eGFR (< 90 mL/min/1.73 m2). Despite the more frequent use of intensive oxygen therapy, continuous blood purification, and glucocorticoid treatment, the prognosis of these patients was unsatisfactory, with the incidence of the composite endpoint (15.4% vs. 19.6% vs. 54.5%; P = 0.000) and complications (AKI, respiratory failure, cardiac injury, coagulation disorders, sepsis, etc.) increasing with decreasing eGFR. Kaplan–Meier survival analysis revealed that patients with eGFR < 90 mL/min/1.73 m2 or AKI had significantly escalated risks of reaching the composite endpoint. Multivariate regression analysis showed that renal insufficiency (eGFR < 60 mL/min/1.73 m2) on admission and in-hospital AKI independently predicted poor prognosis among COVID-19 in-patients. And renal impairment on admission was a greater predictor of poor prognosis in non-elderly patients than that in elderly patients. Early and continuous renal-function monitoring and early AKI diagnosis are necessary to predict and prevent the progression of COVID-19.
format article
author Kehong Chen
Yu Lei
Yani He
Fei Xiao
Yan Yu
Xiaodong Lai
Yang Liu
Jiang Wang
Huanzi Dai
author_facet Kehong Chen
Yu Lei
Yani He
Fei Xiao
Yan Yu
Xiaodong Lai
Yang Liu
Jiang Wang
Huanzi Dai
author_sort Kehong Chen
title Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan
title_short Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan
title_full Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan
title_fullStr Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan
title_full_unstemmed Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan
title_sort clinical outcomes of hospitalized covid-19 patients with renal injury: a multi-hospital observational study from wuhan
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8d31feb4fb1a40e08e774fcf98e19b0e
work_keys_str_mv AT kehongchen clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
AT yulei clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
AT yanihe clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
AT feixiao clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
AT yanyu clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
AT xiaodonglai clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
AT yangliu clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
AT jiangwang clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
AT huanzidai clinicaloutcomesofhospitalizedcovid19patientswithrenalinjuryamultihospitalobservationalstudyfromwuhan
_version_ 1718383886886502400